Finance

Lists
VVOS:NASDAQ
Vivos Therapeutics Inc
$0.18
-3.06%
(-0.0057) 1D
Sep 8, 11:10:28 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VVOS...
Open
$0.18
High
$0.19
Low
$0.17
Mkt. cap
3.57M
Avg. vol.
21.64M
Volume
4.25M
52-wk high
$4.02
52-wk low
$0.16
EPS
-$1.88
Beta
6.04
Shares outstanding
20.12M
No. of employees
270
Open
$0.18
High
$0.19
Low
$0.17
Mkt. cap
3.57M
Avg. vol.
21.64M
Volume
4.25M
52-wk high
$4.02
52-wk low
$0.16
EPS
-$1.88
Beta
6.04
Shares outstanding
20.12M
No. of employees
270
News stories
From web sources and news partners
About Vivos Therapeutics Inc
CEO-
Employees270
Founded2016
HeadquartersLittleton, Colorado, United States
SectorHealth care provider
Websitevivos.com
Analyst ratings
Based on 1 analyst giving stock ratings to VVOS in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for VVOS in the last 3 months
Highest
Current $0.18
$0.75 (+315.05%)
Average
$0.75 (+315.05%)
Lowest
$0.75 (+315.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Hold
Maintained
$0.75
+315.1%
07/08/2026
Lucas Ward
Ascendiant
Buy
Reiterated
$3.10
+1,615.6%
06/04/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$2.50
+1,283.5%
04/17/2026
Unknown Analyst
Alliance Global Partners
Hold
Maintained
$2.50
+1,283.5%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.78M
3.82M
5.14M
5.15M
Cost of goods sold
2.85M
836.00K
2.08M
2.20M
Cost of revenue
2.85M
836.00K
2.08M
2.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.29M
8.93M
9.22M
7.27M
Operating expense
8.67M
9.37M
9.67M
7.78M
Total operating expenses
11.52M
10.21M
11.76M
9.98M
Operating income
-4.73M
-6.38M
-6.62M
-4.82M
Other non operating income
-666.00K
-572.00K
-1.14M
102.00K
EBT including unusual items
-5.40M
-6.95M
-7.75M
-5.52M
EBT excluding unusual items
-5.40M
-6.95M
-7.75M
-5.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.40M
-6.89M
-7.68M
-5.48M
Net profit margin
-79.61%
-180.28%
-149.43%
-106.37%
Earnings per share
-0.49
-0.58
-0.52
-0.31
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-1.10M
Net interest expenses
-
-
-
-1.10M
Depreciation and amortization charges
384.00K
442.00K
454.00K
510.00K
EBITDA
-4.35M
-5.94M
-6.16M
-4.31M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps